Skip to main content
. 2021 Jul 30;10(15):3398. doi: 10.3390/jcm10153398

Table 1.

Description of the characteristics of the patients in training dataset and in the test dataset.

Training Dataset
877 (100%)
Test Dataset
154 (100%)
Age at diagnosis (years) <40 315 (35.9%) 74 (48.1%)
40–50 146 (16.6%) 24 (15.6%)
50–60 134 (15.3%) 19 (12.3%)
>60 282 (32.2%) 37 (24.0%)
Sex Female 534 (60.9%) 78 (50.6%)
Male 343 (39.1%) 76 (49.4%)
Ethnic group Caucasian 676 (77.1%) 127 (82.5%)
Sub-Saharan African 12 (1.4%) 5 (3.2%)
North African 157 (17.9%) 22 (14.3%)
South American 11 (1.3%) 0
Other 7 (0.8%) 0
Asian 14 (1.6%) 0
Anatomic type Anterior uveitis 311 (35.5%) 103 (66.9%)
Combined uveitis 104 (11.9%) 6 (3.9%)
Panuveitis 267 (30.4%) 19 (12.3%)
Posterior uveitis 111 (12.7%) 14 (9.1%)
Intermediate uveitis 84 (9.6%) 12 (7.8%)
Chronicity Acute 292 (33.3%) 144 (93.5%)
Chronic 585 (66.7%) 10 (6.5%)
Laterality Bilateral 515 (58.7%) 40 (26.0%)
Unilateral 362 (41.3%) 114 (74.0%)
Not available 3 (0.3%) 0
Granulomatous character No 614 (70.0%) 120 (77.9%)
Yes 263 (30.0%) 34 (22.1%)
Not available 8 (0.9%) 0
Vasculitis No 793 (88.4%) 132 (85.2%)
Yes 104 (11.6%) 23 (14.8%)
Ocular hypertension No 804 (91.7%) 137 (89.0%)
Yes 73 (8.3%) 17 (11.0%)
Not available 9 (1.0%) 0
Etiology Idiopathic uveitis 431 (49.1%) 103 (66.9%)
Sarcoidosis 191 (21.8%) 8 (5.2%)
Spondyloarthritis & HLA-B27-related 119 (13.6%) 30 (19.5%)
Tuberculosis 59 (6.7%) 1 (0.6%)
Behcet’s disease 30 (3.4%) 3 (1.9%)
Multiple sclerosis 22 (2.5%) 2 (1.3%)
Lymphoma 15 (1.7%) 2 (1.3%)
Other inflammatory diseases 10 (1.1%) 5 (3.2%)